Docosahexaenoic Acid and Arachidonic Acid Nutrition in Early Development

Advances in Pediatrics

Volumn 63, Issue 1, 2016, Pages 453-471

  Carlson, Susan E ^a   Colombo, John ^b,c  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS   (United States)

Author keywords

Allergy; Arachidonic acid (ARA); Cognition; Development; Docosahexaenoic acid (DHA); Growth; Long chain polyunsaturated fatty acids (LCPUFA); Programming

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID;

ARTIFICIAL MILK; BODY COMPOSITION; BRAIN; BREAST MILK; CHEMISTRY; CHILD; CHILD DEVELOPMENT; COGNITION; DIETARY SUPPLEMENT; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; INFANT; INFANT NUTRITION; SINGLE NUCLEOTIDE POLYMORPHISM;

ARACHIDONIC ACID; BODY COMPOSITION; BRAIN; CHILD; CHILD DEVELOPMENT; COGNITION; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; HUMANS; HYPERSENSITIVITY; INFANT; INFANT FORMULA; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MILK, HUMAN; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84971629759     PISSN: 00653101     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yapd.2016.04.011     Document Type: Review

References (113)

1. [1] Svennerholm, L., Vanier, M.T., The distribution of lipids in the human nervous system. 3. Fatty acid composition of phosphoglycerides of human foetal and infant brain. Brain Res 50:2 (1973), 341–351.
2. [2] Martinez, M., Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 120:4 Pt 2 (1992), S129–S138.
3. [3] Martinez, M., Mougan, I., Fatty acid composition of human brain phospholipids during normal development. J Neurochem 71:6 (1998), 2528–2533.
4. [4] Clandinin, M.T., Chappell, J.E., Leong, S., et al. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 4:2 (1980), 121–129.
5. [5] Clandinin, M.T., Chappell, J.E., Leong, S., et al. Extrauterine fatty acid accretion in infant brain: implications for fatty acid requirements. Early Hum Dev 4:2 (1980), 131–138.
6. [6] Martinez, M., Developmental profiles of polyunsaturated fatty acids in the brain of normal infants and patients with peroxisomal diseases: severe deficiency of docosahexaenoic acid in Zellweger's and pseudo-Zellweger's syndromes. World Rev Nutr Diet 66 (1991), 87–102.
7. [7] Sanders, T.A., Ellis, F.R., Dickerson, J.W., Studies of vegans: the fatty acid composition of plasma choline phosphoglycerides, erythrocytes, adipose tissue, and breast milk, and some indicators of susceptibility to ischemic heart disease in vegans and omnivore controls. Am J Clin Nutr 31:5 (1978), 805–813.
8. [8] Ruan, C., Liu, X., Man, H., et al. Milk composition in women from five different regions of China: the great diversity of milk fatty acids. J Nutr 125:12 (1995), 2993–2998.
9. [9] Brenna, J.T., Varamini, B., Jensen, R.G., et al. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am J Clin Nutr 85:6 (2007), 1457–1464.
10. [10] Putnam, J.C., Carlson, S.E., DeVoe, P.W., et al. The effect of variations in dietary fatty acids on the fatty acid composition of erythrocyte phosphatidylcholine and phosphatidylethanolamine in human infants. Am J Clin Nutr 36:1 (1982), 106–114.
11. [11] Jensen, C.L., Voigt, R.G., Prager, T.C., et al. Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. Am J Clin Nutr 82:1 (2005), 125–132.
12. [12] Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies. DHA and ARA and Visual Development: Scientific substantiation of a health claim related to docosahexaenoic acid (DHA) and arachidonic acid (ARA) and visual development pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA J 941 (2009), 1–14.
13. [13] Sanders, T.A., Naismith, D.J., A comparison of the influence of breast-feeding and bottle-feeding on the fatty acid composition of the erythrocytes. Br J Nutr 41:3 (1979), 619–623.
14. [14] Makrides, M., Neumann, M.A., Byard, R.W., et al. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr 60:2 (1994), 189–194.
15. [15] Farquharson, J., Cockburn, F., Patrick, W.A., et al. Infant cerebral cortex phospholipid fatty-acid composition and diet. Lancet 340:8823 (1992), 810–813.
16. [16] Byard, R.W., Makrides, M., Need, M., et al. Sudden infant death syndrome: effect of breast and formula feeding on frontal cortex and brainstem lipid composition. J Paediatr Child Health 31:1 (1995), 14–16.
17. [17] Svennerholm, L., Distribution and fatty acid composition of phosphoglycerides in normal human brain. J Lipid Res 9:5 (1968), 570–579.
18. [18] Hsieh, A.T., Anthony, J.C., Diersen-Schade, D.A., et al. The influence of moderate and high dietary long chain polyunsaturated fatty acids (LCPUFA) on baboon neonate tissue fatty acids. Pediatr Res 61:5 Pt 1 (2007), 537–545.
19. [19] Minns, L.M., Kerling, E.H., Neely, M.R., et al. Toddler formula supplemented with docosahexaenoic acid (DHA) improves DHA status and respiratory health in a randomized, double-blind, controlled trial of US children less than 3 years of age. Prostaglandins Leukot Essent Fatty Acids 82:4–6 (2010), 287–293.
20. [20] Haggarty, P., Fatty acid supply to the human fetus. Annu Rev Nutr 30 (2010), 237–255.
21. [21] Papanikolaou, Y., Brooks, J., Reider, C., et al. U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003-2008. Nutr J, 13, 2014, 31.
22. [22] Gibson, R.A., Neumann, M.A., Lien, E.L., et al. Docosahexaenoic acid synthesis from alpha-linolenic acid is inhibited by diets high in polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 88:1 (2013), 139–146.
23. [23] Blasbalg, T.L., Hibbeln, J.R., Ramsden, C.E., et al. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr 93:5 (2011), 950–962.
24. [24] Guyenet, S.J., Carlson, S.E., Increase in adipose tissue linoleic acid of US adults in the last half century. Adv Nutr 6:6 (2015), 660–664.
25. [25] Sprecher, H., Chen, Q., Polyunsaturated fatty acid biosynthesis: a microsomal-peroxisomal process. Prostaglandins Leukot Essent Fatty Acids 60:5–6 (1999), 317–321.
26. [26] Burdge, G.C., Wootton, S.A., Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 88:4 (2002), 411–420.
27. [27] Schaeffer, L., Gohlke, H., Muller, M., et al. Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 15:11 (2006), 1745–1756.
28. [28] Koletzko, B., Lattka, E., Zeilinger, S., et al. Genetic variants of the fatty acid desaturase gene cluster predict amounts of red blood cell docosahexaenoic and other polyunsaturated fatty acids in pregnant women: findings from the Avon Longitudinal Study of Parents and Children. Am J Clin Nutr 93:1 (2011), 211–219.
29. [29] Xie, L., Innis, S.M., Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. J Nutr 138:11 (2008), 2222–2228.
30. [30] Lattka, E., Illig, T., Koletzko, B., et al. Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism. Curr Opin Lipidol 21:1 (2010), 64–69.
31. [31] Scholtz, S.A., Kerling, E.H., Shaddy, D.J., et al. Docosahexaenoic acid (DHA) supplementation in pregnancy differentially modulates arachidonic acid and DHA status across FADS genotypes in pregnancy. Prostaglandins Leukot Essent Fatty Acids 94 (2015), 29–33.
32. [32] Nguyen, T.L., Kim, C.K., Cho, J.H., et al. Neuroprotection signaling pathway of nerve growth factor and brain-derived neurotrophic factor against staurosporine induced apoptosis in hippocampal H19-7/IGF-IR [corrected]. Exp Mol Med 42:8 (2010), 583–595.
33. [33] Zhou, Y., Wong, C.O., Cho, K.J., et al. SIGNAL TRANSDUCTION. Membrane potential modulates plasma membrane phospholipid dynamics and K-Ras signaling. Science 349:6250 (2015), 873–876.
34. [34] Kim, H.Y., Huang, B.X., Spector, A.A., Phosphatidylserine in the brain: metabolism and function. Prog Lipid Res 56 (2014), 1–18.
35. [35] Northstone, K., Emmett, P.M., Are dietary patterns stable throughout early and mid-childhood? A birth cohort study. Br J Nutr 100:5 (2008), 1069–1076.
36. [36] Northstone, K., Emmett, P., Multivariate analysis of diet in children at four and seven years of age and associations with socio-demographic characteristics. Eur J Clin Nutr 59:6 (2005), 751–760.
37. [37] Allan, K., Devereux, G., Diet and asthma: nutrition implications from prevention to treatment. J Am Diet Assoc 111:2 (2011), 258–268.
38. [38] Kim, H.Y., Moon, H.S., Cao, D., et al. N-Docosahexaenoylethanolamide promotes development of hippocampal neurons. Biochem J 435:2 (2011), 327–336.
39. [39] Trautmann, S.M., Sharkey, K.A., The endocannabinoid system and its role in regulating the intrinsic neural circuitry of the gastrointestinal tract. Int Rev Neurobiol 125 (2015), 85–126.
40. [40] Morena, M., De Castro, V., Gray, J.M., et al. Training-associated emotional arousal shapes endocannabinoid modulation of spatial memory retrieval in rats. J Neurosci 35:41 (2015), 13962–13974.
41. [41] Casado-Diaz, A., Santiago-Mora, R., Dorado, G., et al. The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis. Osteoporos Int 24:5 (2013), 1647–1661.
42. [42] Spencer-Smith, M.M., Spittle, A.J., Lee, K.J., et al. Bayley-III cognitive and language scales in preterm children. Pediatrics 135:5 (2015), e1258–e1265.
43. [43] Stiles, J., Jernigan, T.L., The basics of brain development. Neuropsychol Rev 20:4 (2010), 327–348.
44. [44] Kostovic, I., Jovanov-Milosevic, N., The development of cerebral connections during the first 20-45 weeks' gestation. Semin Fetal Neonatal Med 11:6 (2006), 415–422.
45. [45] Nadarajah, B., Alifragis, P., Wong, R.O., et al. Neuronal migration in the developing cerebral cortex: observations based on real-time imaging. Cereb Cortex 13:6 (2003), 607–611.
46. [46] Pakkenberg, B., Gundersen, H.J., Neocortical neuron number in humans: effect of sex and age. J Comp Neurol 384:2 (1997), 312–320.
47. [47] Maravall, M., Koh, I.Y., Lindquist, W.B., et al. Experience-dependent changes in basal dendritic branching of layer 2/3 pyramidal neurons during a critical period for developmental plasticity in rat barrel cortex. Cereb Cortex 14:6 (2004), 655–664.
48. [48] Huttenlocher, P.R., de Courten, C., Garey, L.J., et al. Synaptogenesis in human visual cortex–evidence for synapse elimination during normal development. Neurosci Lett 33:3 (1982), 247–252.
49. [49] Paolicelli, R.C., Bolasco, G., Pagani, F., et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333:6048 (2011), 1456–1458.
50. [50] Brody, B.A., Kinney, H.C., Kloman, A.S., et al. Sequence of central nervous system myelination in human infancy. I. An autopsy study of myelination. J Neuropathol Exp Neurol 46:3 (1987), 283–301.
51. [51] Lemaire, V., Koehl, M., Le Moal, M., et al. Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proc Natl Acad Sci U S A 97:20 (2000), 11032–11037.
52. [52] Murmu, M.S., Salomon, S., Biala, Y., et al. Changes of spine density and dendritic complexity in the prefrontal cortex in offspring of mothers exposed to stress during pregnancy. Eur J Neurosci 24:5 (2006), 1477–1487.
53. [53] Coe, C.L., Kramer, M., Czeh, B., et al. Prenatal stress diminishes neurogenesis in the dentate gyrus of juvenile rhesus monkeys. Biol Psychiatry 54:10 (2003), 1025–1034.
54. [54] Colombo, J., The critical period concept: research, methodology, and theoretical issues. Psychol Bull 91:2 (1982), 260–275.
55. [55] Armitage, J.A., Taylor, P.D., Poston, L., Experimental models of developmental programming: consequences of exposure to an energy rich diet during development. J Physiol 565:Pt 1 (2005), 3–8.
56. [56] Langley-Evans, S.C., Developmental programming of health and disease. Proc Nutr Soc 65:1 (2006), 97–105.
57. [57] Taylor, P.D., Poston, L., Developmental programming of obesity in mammals. Exp Physiol 92:2 (2007), 287–298.
58. [58] Colombo, J., The development of visual attention in infancy. Annu Rev Psychol 52 (2001), 337–367.
59. [59] Boothe, R.G., Dobson, V., Teller, D.Y., Postnatal development of vision in human and nonhuman primates. Annu Rev Neurosci 8 (1985), 495–545.
60. [60] Chugani, H.T., Phelps, M.E., Mazziotta, J.C., Positron emission tomography study of human brain functional development. Ann Neurol 22:4 (1987), 487–497.
61. [61] Colombo, J., Cheatham, C.L., The emergence and basis of endogenous attention in infancy and early childhood. Adv Child Dev Behav 34 (2006), 283–322.
62. [62] Jacobs, R.A., Computational studies of the development of functionally specialized neural modules. Trends Cogn Sci 3:1 (1999), 31–38.
63. [63] Johnson, M.H., Vecera, S.P., Cortical differentiation and neurocognitive development: The parcellation conjecture. Behav Processes 36:2 (1996), 195–212.
64. [64] Colombo, J., Infant cognition: predicting later intellectual functioning. 1993, Sage Publications, Newbury Park (CA).
65. [65] Colombo, J., Fagen, J., (eds.) Individual differences in infancy: reliability, stability, prediction, 1990, Psychology Press, New York, 2014.
66. [66] Bornstein, M.H., Sigman, M.D., Continuity in mental development from infancy. Child Dev 57:2 (1986), 251–274.
67. [67] Bornstein, M.H., Hahn, C.S., Bell, C., et al. Stability in cognition across early childhood. A developmental cascade. Psychol Sci 17:2 (2006), 151–158.
68. [68] Bornstein, M.H., Hahn, C.S., Wolke, D., Systems and cascades in cognitive development and academic achievement. Child Dev 84:1 (2013), 154–162.
69. [69] Birch, E.E., Birch, D.G., Hoffman, D.R., et al. Dietary essential fatty acid supply and visual acuity development. Invest Ophthalmol Vis Sci 33:11 (1992), 3242–3253.
70. [70] Carlson, S.E., Werkman, S.H., Rhodes, P.G., et al. Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation. Am J Clin Nutr 58:1 (1993), 35–42.
71. [71] Uauy, R., Hoffman, D.R., Peirano, P., et al. Essential fatty acids in visual and brain development. Lipids 36:9 (2001), 885–895.
72. [72] Birch, E.E., Garfield, S., Castaneda, Y., et al. Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early Hum Dev 83:5 (2007), 279–284.
73. [73] Birch, E.E., Carlson, S.E., Hoffman, D.R., et al. The DIAMOND (DHA Intake and Measurement of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am J Clin Nutr 91:4 (2010), 848–859.
74. [74] Carlson, S.E., Werkman, S.H., A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until two months. Lipids 31:1 (1996), 85–90.
75. [75] Werkman, S.H., Carlson, S.E., A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until nine months. Lipids 31:1 (1996), 91–97.
76. [76] Reisbick, S., Neuringer, M., Gohl, E., et al. Visual attention in infant monkeys: effects of dietary fatty acids and age. Dev Psychol 33:3 (1997), 387–395.
77. [77] Colombo, J., Carlson, S.E., Cheatham, C.L., et al. Long-chain polyunsaturated fatty acid supplementation in infancy reduces heart rate and positively affects distribution of attention. Pediatr Res 70:4 (2011), 406–410.
78. [78] Colombo, J., Carlson, S.E., Cheatham, C.L., et al. Long-term effects of LCPUFA supplementation on childhood cognitive outcomes. Am J Clin Nutr 98:2 (2013), 403–412.
79. [79] Willatts, P., Forsyth, S., Agostoni, C., et al. Effects of long-chain PUFA supplementation in infant formula on cognitive function in later childhood. Am J Clin Nutr 98:2 (2013), 536s–542s.
80. [80] Helland, I.B., Smith, L., Saarem, K., et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 111:1 (2003), e39–e44.
81. [81] Jensen, C.L., Voigt, R.G., Llorente, A.M., et al. Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants. J Pediatr 157:6 (2010), 900–905.
82. [82] Cheatham, C.L., Nerhammer, A.S., Asserhoj, M., et al. Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids 46:7 (2011), 637–645.
83. [83] Westerberg, A.C., Schei, R., Henriksen, C., et al. Attention among very low birth weight infants following early supplementation with docosahexaenoic and arachidonic acid. Acta Paediatr 100:1 (2011), 47–52.
84. [84] Almaas, A.N., Tamnes, C.K., Nakstad, B., et al. Long-chain polyunsaturated fatty acids and cognition in VLBW infants at 8 years: an RCT. Pediatrics 135:6 (2015), 972–980.
85. [85] Collins, C.T., Gibson, R.A., Anderson, P.J., et al. Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial. BMJ Open, 5(3), 2015, e007314.
86. [86] Isaacs, E.B., Ross, S., Kennedy, K., et al. 10-year cognition in preterms after random assignment to fatty acid supplementation in infancy. Pediatrics 128:4 (2011), e890–e898.
87. [87] Drover, J.R., Hoffman, D.R., Castaneda, Y.S., et al. Cognitive function in 18-month-old term infants of the DIAMOND study: a randomized, controlled clinical trial with multiple dietary levels of docosahexaenoic acid. Early Hum Dev 87:3 (2011), 223–230.
88. [88] Drover, J.R., Felius, J., Hoffman, D.R., et al. A randomized trial of DHA intake during infancy: school readiness and receptive vocabulary at 2-3.5 years of age. Early Hum Dev 88:11 (2012), 885–891.
89. [89] Colombo, J., Carlson, S.E., Is the measure the message: the BSID and nutritional interventions. Pediatrics 129:6 (2012), 1166–1167.
90. [90] Liao KMB, Carlson SE, Colombo J, et al. Long-chain polyunsaturated fatty acid supplementation in infancy: response inhibition in childhood. Dev Sci, 2016. in press.
91. [91] Grayson, D.S., Kroenke, C.D., Neuringer, M., et al. Dietary omega-3 fatty acids modulate large-scale systems organization in the rhesus macaque brain. J Neurosci 34:6 (2014), 2065–2074.
92. [92] Peters, B.D., Voineskos, A.N., Szeszko, P.R., et al. Brain white matter development is associated with a human-specific haplotype increasing the synthesis of long chain fatty acids. J Neurosci 34:18 (2014), 6367–6376.
93. [93] Martinez, M., Vazquez, E., MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders. Neurology 51:1 (1998), 26–32.
94. [94] Caspi, A., Williams, B., Kim-Cohen, J., et al. Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism. Proc Natl Acad Sci U S A 104:47 (2007), 18860–18865.
95. [95] Steer, C.D., Davey Smith, G., Emmett, P.M., et al. FADS2 polymorphisms modify the effect of breastfeeding on child IQ. PLoS One, 5(7), 2010, e11570.
96. [96] Rizzi, T.S., van der Sluis, S., Derom, C., et al. Genetic variance in combination with fatty acid intake might alter composition of the fatty acids in brain. PLoS One, 8(6), 2013, e68000.
97. [97] Reardon, H.T., Zhang, J., Kothapalli, K.S., et al. Insertion-deletions in a FADS2 intron 1 conserved regulatory locus control expression of fatty acid desaturases 1 and 2 and modulate response to simvastatin. Prostaglandins Leukot Essent Fatty Acids 87:1 (2012), 25–33.
98. [98] Duchen, K., Yu, G., Bjorksten, B., Atopic sensitization during the first year of life in relation to long chain polyunsaturated fatty acid levels in human milk. Pediatr Res 44:4 (1998), 478–484.
99. [99] Duchen, K., Casas, R., Fageras-Bottcher, M., et al. Human milk polyunsaturated long-chain fatty acids and secretory immunoglobulin A antibodies and early childhood allergy. Pediatr Allergy Immunol 11:1 (2000), 29–39.
100. [100] Barman, M., Nilsson, S., Torinsson Naluai, A., et al. Single nucleotide polymorphisms in the FADS gene cluster but not the ELOVL2 gene are associated with serum polyunsaturated fatty acid composition and development of allergy (in a Swedish birth cohort). Nutrients 7:12 (2015), 10100–10115.
101. [101] Field, C.J., Van Aerde, J.E., Robinson, L.E., et al. Effect of providing a formula supplemented with long-chain polyunsaturated fatty acids on immunity in full-term neonates. Br J Nutr 99:1 (2008), 91–99.
102. [102] Birch, E.E., Khoury, J.C., Berseth, C.L., et al. The impact of early nutrition on incidence of allergic manifestations and common respiratory illnesses in children. J Pediatr 156:6 (2010), 902–906 906.e1.
103. [103] Foiles, A.M., Kerling, E.H., Wick, J.A., et al. Formula with long chain polyunsaturated fatty acids reduces incidence of allergy in early childhood. Pediatr Allergy Immunol 27:2 (2016), 156–161.
104. [104] Furuhjelm, C., Jenmalm, M.C., Falth-Magnusson, K., et al. Th1 and Th2 chemokines, vaccine-induced immunity, and allergic disease in infants after maternal omega-3 fatty acid supplementation during pregnancy and lactation. Pediatr Res 69:3 (2011), 259–264.
105. [105] Jenmalm, M.C., Duchen, K., Timing of allergy-preventive and immunomodulatory dietary interventions - are prenatal, perinatal or postnatal strategies optimal?. Clin Exp Allergy 43:3 (2013), 273–278.
106. [106] Best, K.P., Gold, M., Kennedy, D., et al. Omega-3 long-chain PUFA intake during pregnancy and allergic disease outcomes in the offspring: a systematic review and meta-analysis of observational studies and randomized controlled trials. Am J Clin Nutr 103:1 (2016), 128–143.
107. [107] Hutley, L.J., Newell, F.M., Joyner, J.M., et al. Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation. Eur J Clin Invest 33:7 (2003), 574–581.
108. [108] Massiera, F., Saint-Marc, P., Seydoux, J., et al. Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern?. J Lipid Res 44:2 (2003), 271–279.
109. [109] Moon, R.J., Harvey, N.C., Robinson, S.M., et al. Maternal plasma polyunsaturated fatty acid status in late pregnancy is associated with offspring body composition in childhood. J Clin Endocrinol Metab 98:1 (2013), 299–307.
110. [110] Much, D., Brunner, S., Vollhardt, C., et al. Breast milk fatty acid profile in relation to infant growth and body composition: results from the INFAT study. Pediatr Res 74:2 (2013), 230–237.
111. [111] Currie, L.M., Long chain polyunsaturated fatty acid supplementation in infancy increases length- and weight-for-age but not BMI to 6 years when controlling for effects of maternal smoking. Prostaglandins Leukot Essent Fatty Acids 98 (2015), 1–6.
112. [112] Murphy, R.A., Yu, E.A., Ciappio, E.D., et al. Suboptimal plasma long chain n-3 concentrations are common among adults in the United States, NHANES 2003-2004. Nutrients 7:12 (2015), 10282–10289.
113. [113] Forsyth, S., Why are we undertaking DHA supplementation studies in infants who are not DHA-deficient?. Br J Nutr, 108(5), 2012, 948.